Becker's Healthcare September 3, 2024
Claire Wallace

A new study has found that patients taking weight loss medications including Ozempic and Wegovy are less likely to die from COVID-19, according to a Sept. 2 report from CNBC.

While individuals taking semaglutide can still contract COVID-19, they had a 33% lower chance of...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Healthcare System, Patient / Consumer, Pharma / Biotech, Public Health / COVID
People on Ozempic may have fewer heart attacks, strokes, addictions—but more nausea, vomiting, stomach pain
Exploring the Future of Genomics and Life Sciences
Pharma is hopeful about Trump's second term — here's what to expect for drugmakers
Novo Nordisk Obesity Drug Shows 22% Weight Loss, But Lack of Safety Detail Is a Sticking Point
Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks

Share This Article